Skip to main content

Table 4 The treatments and outcomes of 24 patients which was classified in pneumonia, lung abscess and bacterial pleurisy only

From: The clinical features of respiratory infections caused by the Streptococcus anginosus group

  Total Pneumonia Lung abscess Bacterial pleurisy only p-Value
  (n = 24) (n = 16) (n = 5) (n = 3)
Monotherapy 20 (83.3) 12 (75.0) 5 (100) 3 (100) NS
 Penicillin/beta-lactamase inhibitors 1 (4.2) 1 (6.3) 0 (0.0) 0 (0.0) NS
 Carbapenem 17 (70.8) 10 (62.5) 4 (80.0) 3 (100) NS
 Linezolid 1 (4.2) 0 (0.0) 1 (20.0) 0 (0.0) NS
 Macrolide 1 (4.2) 1 (6.3) 0 (0.0) 0 (0.0) NS
Combination therapy 4 (16.7) 4 (25.0) 0 (0.0) 0 (0.0) NS
 4th-cephem + Clindamycin 1 (4.2) 1 (6.3) 0 (0.0) 0 (0.0) NS
 Carbapenem + Clindamycin 2 (8.3) 2 (12.5) 0 (0.0) 0 (0.0) NS
 Fluoroquinolone + Clindamycin 1 (4.2) 1 (6.3) 0 (0.0) 0 (0.0) NS
Additional treatment 16 (66.7) 12 (75.0) 1 (20.0) 3 (100) NS
 Only drainage 4 (16.7) 2 (12.5) 1 (20.0) 1 (33.3) NS
 Drainage + lung decortication 12 (50.0) 10 (62.5) 0 (0.0) 2 (66.7) NS
Length of stay (days) 29.3 ± 19.7 31.4 ± 20.9 28.6 ± 21.0 19.0 ± 9.5 NS
ICU admission 6 (25.0) 6 (37.5) 0 (0.0) 0 (0.0) NS
In hospital mortality 2 (8.3) 2 (12.5) 0 (0.0) 0 (0.0) NS
  1. NS not significant, ICU intensive care unit